tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Knight, 123 are a BUY (89.13%), 15 are a HOLD (10.87%).
Analyst Paul Knight, currently employed at KEYBANK, carries an average stock price target met ratio of 54.67% that have a potential upside of 36.35% achieved within 148 days.
Paul Knight’s has documented 272 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.
Most recent stock forecast was given on WST, West Pharmaceutical Services at 23-Oct-2025.
Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for CYRX (CRYOPORT) at 1/19/2021. The price target of $75 was fulfilled within 3 days with a profit of $10.82 (16.86%) receiving and performance score of 56.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$140
$-8.03 (-5.42%)
$130
21 days ago
(06-Oct-2025)
6/6 (100%)
$1.44 (1.04%)
38
Hold
$150
$1.97 (1.33%)
$125
26 days ago
(01-Oct-2025)
15/16 (93.75%)
$11.3 (8.15%)
128
Buy
$150
$1.97 (1.33%)
$116
1 months 13 days ago
(14-Sep-2025)
15/20 (75%)
$24.62 (19.64%)
366
Buy
$155
$6.97 (4.71%)
$165
4 months 29 days ago
(28-May-2025)
7/10 (70%)
$42.18 (37.39%)
278
Hold
$150
$1.97 (1.33%)
$147
10 months 15 days ago
(12-Dec-2024)
8/8 (100%)
$12.12 (8.79%)
99
Which stock is Paul Knight is most bullish on?
Which stock is Paul Knight is most reserved on?
What Year was the first public recommendation made by Paul Knight?
